Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MENISC-T for STT Osteoarthritis
NCT05250726Phase 2Completed
- Sponsor
- TBF Génie Tissulaire
- Start
- Jan 2021
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by TBF Génie Tissulaire. Primary endpoint: Decrease of the symptomatology related to the STT OA at 12 months. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT05250726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05250726.